Selva Therapeutics
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.selvarx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Selva Therapeutics
Selva Therapeutics is a biotechnology company focused on developing therapeutics for infectious diseases, notably their lead drug candidate SLV213, which is an antiviral therapy capable of combatting a variety of viral infections including COVID-19, Ebola, and Chagas disease. The company aims to provide effective treatments that protect global health by rapidly advancing SLV213 through clinical trials. This oral drug is designed for outpatient use, offering a preferred treatment option for mild to moderate infections. Selva Therapeutics continues to research SLV213's broad-spectrum efficacy against multiple infectious diseases while emphasizing its unique mechanism of action.Explore more
Selva Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Selva Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Selva Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Selva Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Selva Therapeutics
Check out if Selva Therapeutics is spiking on competitors!
Check if Selva Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Selva Therapeutics launches new products
Click to see if Selva Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Selva Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Selva Therapeutics
Compare insights from companies similar to Selva Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Selva Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Selva Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Selva Therapeutics.
Selva Therapeutics financials insights
Gather financial insights about Selva Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$3M
Selva Therapeutics Tech Stack
A closer look at the technologies used by Selva Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Selva Therapeutics
Sign Up For FreeTo access detailed company insights
Selva Therapeutics is a biotechnology company focused on developing therapeutics for infectious diseases, notably their lead drug candidate SLV213, which is an antiviral therapy capable of combatting a variety of viral infections including COVID-19, Ebola, and Chagas disease. The company aims to provide effective treatments that protect global heal... Read More
